ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,347, issued on Aug. 4, was assigned to Silver Creek Pharmaceuticals Inc. (San Francisco).

"Bi-specific fusion proteins" was invented by Ulrik Nielsen (Quincy, Mass.), Thomas Wickham (Groton, Mass.), Birgit Schoeberl (Cambridge, Mass.), Brian Harms (Roslindale, Mass.), Bryan Linggi (Richland, Wash.), Matthew Onsum (El Cerrito, Calif.), Byron DeLaBarre (Cambridge, Mass.) and Shaun M. Lippow (San Francisco).

According to the abstract* released by the U.S. Patent & Trademark Office: "Bi-specific fusion proteins with therapeutic uses are provided, as well as pharmaceutical compositions comprising such fusion proteins, and methods for using such fusion proteins to repair or regenerate d...